Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1046 | 905 | 1117 | 1022 | 1274 | 1931 |
Fund Return | 4.56% | -9.47% | 11.74% | 0.72% | 4.96% | 6.8% |
Place in category | 629 | 761 | 514 | 309 | 276 | 107 |
% in Category | 60 | 78 | 53 | 48 | 59 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquUG | 2.04B | 5.66 | 1.88 | 8.04 | ||
Wellington Global Health Care EquiN | 2.04B | 5.18 | 1.37 | 7.49 | ||
Wellington Global Health Care EquiS | 2.04B | -2.69 | -2.90 | 6.48 | ||
Wellington Enduring Assets Fund USD | 558.16M | 21.47 | 7.16 | 6.95 | ||
Wellington Emerging Markets EquityT | 35.7M | 8.35 | -2.62 | 4.74 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund A U | 4B | 1.72 | 0.86 | 6.56 | ||
Janus Global Life Sciences Fund I U | 4B | 2.56 | 1.68 | 7.40 | ||
Wellington Global Health Care EquUG | 2.04B | 5.66 | 1.88 | 8.04 | ||
Wellington Global Health Care EquiN | 2.04B | 5.18 | 1.37 | 7.49 | ||
Wellington Global Health Care EquiS | 2.04B | -2.69 | -2.90 | 6.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.93 | 868.88 | -1.07% | |
UnitedHealth | US91324P1021 | 7.35 | 533.37 | +1.20% | |
Novo Nordisk B | DK0062498333 | 5.70 | 615.4 | -2.15% | |
Merck&Co | US58933Y1055 | 4.33 | 86.40 | -1.01% | |
AstraZeneca | GB0009895292 | 4.26 | 11,718.0 | +1.02% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Neutral |
Technical Indicators | Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review